CTA
EHC icon

Carillon Tower Advisers’s Encompass Health EHC Stock Holding History

Carillon Tower Advisers’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-438,403
Closed -$22.1M – 476
2019
Q2 		$22.1M Hold
438,403
– – 0.15% 239
2019
Q1 		$20.4M Hold
438,403
– – 0.14% 238
2018
Q4 		$21.5M Hold
438,403
– – 0.18% 207
2018
Q3 		$27.2M Sell
438,403
-556,382
-56% -$33.8M 0.19% 184
2018
Q2 		$53.6M Buy
994,785
+28,469
+3% +$1.42M 0.42% 71
2018
Q1 		$42.8M Hold
966,316
– – 0.33% 92
2017
Q4 		$38M Buy
+966,316
New +$36.8M 0.4% 88

Other funds holding EHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Carillon Tower Advisers's EHC Position: Q3 2019 in Review

Carillon Tower Advisers sold out of Encompass Health (EHC) in Q3 2019, closing a stake of 438,403 shares — an estimated $22.1M sold.

Carillon Tower Advisers first reported a position in EHC in Q4 2017 and held it in 7 quarters. The position peaked at $53.6M in Q2 2018. 360 funds tracked by Wall St. Rank hold EHC as of Q3 2019.

  • Carillon Tower Advisers reported no remaining Encompass Health position as of Q3 2019 after selling out during the quarter.
  • Carillon Tower Advisers sold 438,403 Encompass Health shares in Q3 2019, an estimated $22.1M.
  • Carillon Tower Advisers first reported a position in Encompass Health in Q4 2017 and held it in 7 quarters.
  • Carillon Tower Advisers's Encompass Health position peaked at $53.6M in Q2 2018.
  • 360 funds tracked by Wall St. Rank held Encompass Health as of Q3 2019.

Based on Carillon Tower Advisers's 13F filing for Q3 2019, filed 5 Nov 2019.